Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance

A. Di Troia, M. Carpo, N. Meucci, C. Pellegrino, S. Allaria, F. Gemignani, A. Marbini, R. Mantegazza, R. Sciolla, E. Manfredini, G. Scarlato, E. Nobile-Orazio

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Neuropathy has been frequently reported in patients with IgG monoclonal gammopathy of undetermined significance (MGUS) but it is still unclear whether this association has clinical or pathogenetic relevance. In order to clarify the possible role of IgG MGUS in the neuropathy we correlated the clinical and electrophysiological features of the neuropathy with the duration and anti-neural activity of the M-protein in 17 patients with neuropathy and IgG MGUS. Ten patients (59%) had a chronic demyelinating neuropathy clinically indistinguishable from chronic inflammatory demyelinating polyneuropathy (CIDP) while 7 (41%) had a predominantly sensory axonal or mixed neuropathy. In 80% of patients in the CIDP-like and 28% in the sensory group the IgG M-protein became manifest several months to years after onset of the neuropathy. Antibodies to one or more neural antigens (including tubulin, a 35KD P0-like nerve myelin glycoprotein, GD1a, GM1 and chondrotin sulfate C) were found in 40% of patients with CIDP-like and 43% with sensory neuropathy but also in 37% patients with IgG MGUS without neuropathy. Neuropathy associated with IgG MGUS is probably less heterogeneous than previously considered suggesting that this association may not be merely casual. The evidence for primary pathogenetic role of IgG M- proteins in the neuropathy remains however elusive.

Original languageEnglish
Pages (from-to)64-71
Number of pages8
JournalJournal of the Neurological Sciences
Volume164
Issue number1
DOIs
Publication statusPublished - Mar 15 1999

Fingerprint

Monoclonal Gammopathy of Undetermined Significance
Immunoglobulin G
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Proteins
Tubulin
Myelin Sheath
Sulfates
Glycoproteins
Antigens
Antibodies

Keywords

  • Autoantibodies
  • Chondroitin sulfate C
  • CIDP
  • IgG
  • Monoclonal gammopathy
  • Neuropathy
  • Tubulin

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance. / Di Troia, A.; Carpo, M.; Meucci, N.; Pellegrino, C.; Allaria, S.; Gemignani, F.; Marbini, A.; Mantegazza, R.; Sciolla, R.; Manfredini, E.; Scarlato, G.; Nobile-Orazio, E.

In: Journal of the Neurological Sciences, Vol. 164, No. 1, 15.03.1999, p. 64-71.

Research output: Contribution to journalArticle

Di Troia, A, Carpo, M, Meucci, N, Pellegrino, C, Allaria, S, Gemignani, F, Marbini, A, Mantegazza, R, Sciolla, R, Manfredini, E, Scarlato, G & Nobile-Orazio, E 1999, 'Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance', Journal of the Neurological Sciences, vol. 164, no. 1, pp. 64-71. https://doi.org/10.1016/S0022-510X(99)00049-0
Di Troia, A. ; Carpo, M. ; Meucci, N. ; Pellegrino, C. ; Allaria, S. ; Gemignani, F. ; Marbini, A. ; Mantegazza, R. ; Sciolla, R. ; Manfredini, E. ; Scarlato, G. ; Nobile-Orazio, E. / Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance. In: Journal of the Neurological Sciences. 1999 ; Vol. 164, No. 1. pp. 64-71.
@article{3c91c54a94124273864b38c90ec567b7,
title = "Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance",
abstract = "Neuropathy has been frequently reported in patients with IgG monoclonal gammopathy of undetermined significance (MGUS) but it is still unclear whether this association has clinical or pathogenetic relevance. In order to clarify the possible role of IgG MGUS in the neuropathy we correlated the clinical and electrophysiological features of the neuropathy with the duration and anti-neural activity of the M-protein in 17 patients with neuropathy and IgG MGUS. Ten patients (59{\%}) had a chronic demyelinating neuropathy clinically indistinguishable from chronic inflammatory demyelinating polyneuropathy (CIDP) while 7 (41{\%}) had a predominantly sensory axonal or mixed neuropathy. In 80{\%} of patients in the CIDP-like and 28{\%} in the sensory group the IgG M-protein became manifest several months to years after onset of the neuropathy. Antibodies to one or more neural antigens (including tubulin, a 35KD P0-like nerve myelin glycoprotein, GD1a, GM1 and chondrotin sulfate C) were found in 40{\%} of patients with CIDP-like and 43{\%} with sensory neuropathy but also in 37{\%} patients with IgG MGUS without neuropathy. Neuropathy associated with IgG MGUS is probably less heterogeneous than previously considered suggesting that this association may not be merely casual. The evidence for primary pathogenetic role of IgG M- proteins in the neuropathy remains however elusive.",
keywords = "Autoantibodies, Chondroitin sulfate C, CIDP, IgG, Monoclonal gammopathy, Neuropathy, Tubulin",
author = "{Di Troia}, A. and M. Carpo and N. Meucci and C. Pellegrino and S. Allaria and F. Gemignani and A. Marbini and R. Mantegazza and R. Sciolla and E. Manfredini and G. Scarlato and E. Nobile-Orazio",
year = "1999",
month = "3",
day = "15",
doi = "10.1016/S0022-510X(99)00049-0",
language = "English",
volume = "164",
pages = "64--71",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance

AU - Di Troia, A.

AU - Carpo, M.

AU - Meucci, N.

AU - Pellegrino, C.

AU - Allaria, S.

AU - Gemignani, F.

AU - Marbini, A.

AU - Mantegazza, R.

AU - Sciolla, R.

AU - Manfredini, E.

AU - Scarlato, G.

AU - Nobile-Orazio, E.

PY - 1999/3/15

Y1 - 1999/3/15

N2 - Neuropathy has been frequently reported in patients with IgG monoclonal gammopathy of undetermined significance (MGUS) but it is still unclear whether this association has clinical or pathogenetic relevance. In order to clarify the possible role of IgG MGUS in the neuropathy we correlated the clinical and electrophysiological features of the neuropathy with the duration and anti-neural activity of the M-protein in 17 patients with neuropathy and IgG MGUS. Ten patients (59%) had a chronic demyelinating neuropathy clinically indistinguishable from chronic inflammatory demyelinating polyneuropathy (CIDP) while 7 (41%) had a predominantly sensory axonal or mixed neuropathy. In 80% of patients in the CIDP-like and 28% in the sensory group the IgG M-protein became manifest several months to years after onset of the neuropathy. Antibodies to one or more neural antigens (including tubulin, a 35KD P0-like nerve myelin glycoprotein, GD1a, GM1 and chondrotin sulfate C) were found in 40% of patients with CIDP-like and 43% with sensory neuropathy but also in 37% patients with IgG MGUS without neuropathy. Neuropathy associated with IgG MGUS is probably less heterogeneous than previously considered suggesting that this association may not be merely casual. The evidence for primary pathogenetic role of IgG M- proteins in the neuropathy remains however elusive.

AB - Neuropathy has been frequently reported in patients with IgG monoclonal gammopathy of undetermined significance (MGUS) but it is still unclear whether this association has clinical or pathogenetic relevance. In order to clarify the possible role of IgG MGUS in the neuropathy we correlated the clinical and electrophysiological features of the neuropathy with the duration and anti-neural activity of the M-protein in 17 patients with neuropathy and IgG MGUS. Ten patients (59%) had a chronic demyelinating neuropathy clinically indistinguishable from chronic inflammatory demyelinating polyneuropathy (CIDP) while 7 (41%) had a predominantly sensory axonal or mixed neuropathy. In 80% of patients in the CIDP-like and 28% in the sensory group the IgG M-protein became manifest several months to years after onset of the neuropathy. Antibodies to one or more neural antigens (including tubulin, a 35KD P0-like nerve myelin glycoprotein, GD1a, GM1 and chondrotin sulfate C) were found in 40% of patients with CIDP-like and 43% with sensory neuropathy but also in 37% patients with IgG MGUS without neuropathy. Neuropathy associated with IgG MGUS is probably less heterogeneous than previously considered suggesting that this association may not be merely casual. The evidence for primary pathogenetic role of IgG M- proteins in the neuropathy remains however elusive.

KW - Autoantibodies

KW - Chondroitin sulfate C

KW - CIDP

KW - IgG

KW - Monoclonal gammopathy

KW - Neuropathy

KW - Tubulin

UR - http://www.scopus.com/inward/record.url?scp=0033560048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033560048&partnerID=8YFLogxK

U2 - 10.1016/S0022-510X(99)00049-0

DO - 10.1016/S0022-510X(99)00049-0

M3 - Article

VL - 164

SP - 64

EP - 71

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1

ER -